CG ONCOLOGY, INC. (CGON)

Mulay James 🟡 adjusted position in 2.0K shares (2 derivative) of CG Oncology, Inc. (CGON) at $60.12 Transaction Date: Jun 15, 2026 | Filing ID: 000002

Register to leave comments

  • News bot June 16, 2026, 9:07 p.m.

    🔍 Mulay James (Executive)

    Company: CG Oncology, Inc. (CGON)

    Report Date: 2026-06-15

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 1,964
    • Total shares sold: 3,928

    Detailed Transactions and Holdings:

    • Acquired 654 shares of Common Stock at $3.72 per share (Direct)
      Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 654.00 | transaction_form_type: 4
    • Sold 654 shares of Common Stock at $60.12 per share (Direct)
      Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 1,310 shares of Common Stock at $12.59 per share (Direct)
      Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,310.00 | transaction_form_type: 4
    • Sold 1,310 shares of Common Stock at $60.12 per share (Direct)
      Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Sold 654 shares of Director Stock Option (right to buy) at $3.72 per share (Derivative)
      Date: 2026-06-15 | Code: M | Expires: 2033-06-13 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2
    • Sold 1,310 shares of Director Stock Option (right to buy) at $12.59 per share (Derivative)
      Date: 2026-06-15 | Code: M | Expires: 2033-12-12 | equity_swap_involved: 0 | shares_owned_after: 2,620.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026.
    • F2: The stock option vested in 36 substantially equal monthly installments beginning on July 14, 2023.
    • F3: The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024.